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Abstract: RNA interference (RNAi) pathway is a gene silencing process during which small double-stranded RNA
(dsRNA) molecules trigger the degradation of homologous RNA targets. Small interfering RNAs (siRNAs) are the
mediators of the RNAi that can be induced in vitro and in vivo by direct application of chemically synthesized siRNAs.
Recently, promoter-targeted small non-coding RNAs have been described to be capable of regulating gene expression
at the transcriptional level. In the present study we tested the hypothesis that Dicer-substrate siRNAs (D-siRNAs),
which trigger gene silencing through intrinsic RNAi pathway and are therefore more potent in gene knockdown than
traditionally used 21-23mer siRNAs, may also display regulatory effects at the transcriptional level. Synthetic 27mer
D-siRNAs targeting the promoter/early coding region of the CDKN2A gene were designed and transfected into HeLa
cells, and 48 h post-transfection the CDKN2A expression was analyzed in quantitative real-time PCR using the housekeeping G6PDH gene as reference. In comparison to the mutant version, the CDKN2A gene was effectively knockeddown by the D-siRNA, but no evidence of transcriptional regulation was found. We conclude that the D-siRNA-induced
suppression is likely to occur after transcription.
Key words: RNA interference, Dicer-substrate siRNAs, transcriptional silencing, CDKN2A

Dicer-substrat siRNA’ların gen ifadesini yazılım aşamasında
düzenleme kabiliyetlerinin test edilmesi
Özet: RNA interferans (RNAi) yolağı, özdeş hedef mRNA moleküllerinin yıkımına yol açarak, gen ifadesinin yazılım
sonrası aşamada düzenlenmesini içerir. Küçük müdahaleci RNA’lar (siRNA’lar), RNAi yolağının aracı molekülleridir ve
RNAi, sentetik siRNA’lar kullanılarak in vitro ve in vivo olarak oluşturulabilir. Güncel çalışmalar, promotör bölgelerine
hedeflendirilmiş küçük kodlamayan RNA’ların gen ifadesini yazılım aşamasında da düzenleyebilme özelliğinde olduğunu
göstermektedir. Bu çalışmada, gen susturulmasını intrinsik RNAi yolağı ile gerçekleştiren ve bu nedenle geleneksel
olarak kullanılan 21-23mer siRNA’lardan daha etkin olduğu gösterilen Dicer-substrate siRNA’ların (D-siRNA’lar)
yazılım aşamasında düzenleyici işlevlere sahip olabileceiği hipotezini test ettik. CDKN2A geninin promotör/erken
kodlayan bölgesine özgül 27-mer D-siRNA ve bunun merkezi bölgesinde 4 adet baz değişimi içeren mutant versiyonu
tasarladı. siRNA’lar HeLa hücrelerine transfekte edildi ve 48 saat sonra CDKN2A ifade düzeyi gerçek-zamanklı PCR’da
yaşamsal gen G6PDH referans olarak kullanılarak değerlendirildi. Mutant versiyon ile karşılaştırıldığında, D-siRNA
etkin bir şekilde CDKN2A geninin susturulmasına yol açtı, ancak baskılanmanın yazılım aşamasında gerçekleştiğine
dair bir bulgu elde edilmedi. Bu bulgulardan yola çıkarak, D-siRNA’nın yol açtığı gen susturulmasının yazılım sonrası
gerçekleştiğini kabul etmekteyiz.
Anahtar sözcükler: RNA interferans, Dicer-substrat siRNA’lar, gen susturulması, CDKN2A
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Introduction
Post-transcriptional gene silencing (PTGS) is
the first described feature of small interfering RNAs
(siRNAs), the main players of the evolutionally
conserved RNA interference (RNAi) pathway. In
PTGS, homologous RNA targets are degraded in
a sequence-specific manner through siRNAs, or
initiation of the translation is inhibited. The RNase
III-like nuclease Dicer plays a central role in RNAi
cleaving long RNA molecules into 21-23 nt siRNAs
with overhanging 3’ ends (1).
Recently, in addition to PTGS small non-coding
RNAs have also been described to display regulatory
effects at the transcriptional level. This regulation
may act in both directions suppressing (2,3), and
activating transcription (4,5), in human cells.
Mechanistically, small RNA-directed transcriptional
gene suppression functions by targeting of epigenetic
modifications (e.g. histone methylations) to gene
promoters (6,7). It has been shown that a low-copy
promoter-associated RNA transcribed through RNA
polymerase II is recognized by the antisense strand of
the siRNA functioning as a recognition motif to attract
epigenetic silencing complexes to the corresponding
targeted promoters leading to transcriptional
silencing (7). However, a more recent study has shown
that promoter-targeting siRNAs, instead of directing
silent epigenetic marks to promoters, interfered with
the initiation of transcription blocking the assembly
of the pre-initiation complex even if a noncoding
promoter-associated RNA was involved in the process
(8). On the other hand, deregulation of endogenous
bidirectional transcription was postulated as the
mechanism of transcriptional activation by small
non-coding RNAs (9). The antisense transcript in
the bidirectionally transcribed gene directs silent
epigenetic marks to the sense gene promoter, and
suppression of the antisense transcript results in gene
activation.
Synthetic siRNAs used in in vitro studies are
traditionally composed of 19-23 bp dsRNAs with
2-base 3’ overhangs. When transfected into cells,
they mimic the product of Dicer cleavage (10). It has
been suggested that, in addition to cleaving longer
dsRNAs, the Dicer endonuclease may direct loading
the processed dsRNA into the RISC assembly. This
hypothesis has led to the development of a new class of
400

siRNAs, termed Dicer-substrate siRNAs (D-siRNAs).
These are 25-30 nt in length and engage Dicer with
high affinity and are passed from Dicer to RISC with
strand-specific orientation (10,11). Of all sizes tested,
the 27mer D-siRNA was found to be approximately
100-fold more potent in silencing the targeted gene
than shorter (21-23mers) or longer (35-45mers)
RNAs (10,12). It is assumed that cleavage by Dicer
and loading to RISC contributes to the increased
potency of D-siRNAs.
It is not known whether D-siRNAs are able to
modulate gene regulation at transcriptional level. In
the present study, we speculated that in addition to
the PTGS D-siRNAs might have modulating activities
at transcriptional level. We tested this hypothesis at
the CpG island of the CDKN2A gene in which the
promoter and early coding region overlap (13). The
reason for choosing this sequence as the target is
that we used non-validated D-siRNAs, and, in the
case that these do not display regulating activities
at the transcriptional level, gene suppression at the
post-transcriptional level would favor the evidence of
functionality of non-validated D-siRNAs.
Materials and methods
Cell culture
HeLa cell line was purchased from the German
Resource Centre for Biological Materials (DSMZ)
(DSMZ no: ACC 57). Cells were grown in the
DMEM culture medium containing NaHCO3
(3.7g/L), glucose (1 g/L), and stabile glutamine
(Biochrom, Berlin, Germany) supplemented with
10% FCS (Biochrom) and antibiotics under standard
conditions (37 °C and 5% CO2 humidity). Cells
were subcultivated at a confluency of 80%-90%. For
siRNA transfection experiments, cells with a passage
number < 10 were used.
Dicer-substrate siRNAs and transfection
A 27mer D-siRNA duplex that corresponds to
the promoter/exon 1 region of the CDKN2A gene
and its mutant version (mD-siRNA) containing 4
central mismatches (Table 1) were designed using
the RNAi Design Tool of IDT Technologies (htpp://
eu.idtdna.com/Scitools/applications/RNA/RNAi.
aspx) and purchased from this company (IDT
Technologies, Coralville, IA, USA). siRNA duplexes
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Table 1. siRNA sequences for targeting the CDKN2A gene (NCBI Accession # NM_058197).

D-siRNA

mD-siRNA

Strand (5’ to 3’)
F
P-GCACCGAAUAGUUACGGUCGGAGgc
R
GCCUCCGACCGUAACUAUUCGGUGCGU
F
R

P-GCACCGAAUCCCCACGGUCGGAGgc
GCCUCCGACCGUGGGGAUUCGGUGCGU

Lower case base pairs indicate DNA; P: phosphorus; F: forward, R: reverse. Underlined bases represent mismatches

were transfected into HeLa cells via lipofection using
the X-tremeGENE siRNA Transfection Reagent
(Roche diagnostics, Mannheim, Germany) using
the manufacturer’s protocol. Briefly, 1 day prior to
transfection, cells were seeded at a concentration
of 1 × 105 cells/well in 12-well plates using 1 mL of
DMEM medium to reach 30%-50% confluency. For
transfection, 3 μL of transfection agent was mixed
with 72 μL of serum-free medium, and 1 μL of siRNA
was diluted in 74 μL of serum-free medium. Diluted
siRNA was added immediately to the transfection
agent and mixed and incubated at RT for 20 min.
Finally, the transfection agent-siRNA complex was
added to the cells in drops, and cells were incubated
under standard growth conditions. Forty-eight hours
after transfection, cells were washed, harvested and
were kept at –80 °C until use for further analysis. To
test the effect of the D-siRNA on the transcription,
prior to harvesting transfected cells were incubated
for additional 24 h in the presence (10 ng/mL) or
absence of trichostatine A (TSA). Transfection
experiments were performed 3 times, and 2 samples
were included in each group. Mean values were
calculated.
Analysis of the CDKN2A gene expression
RNA was extracted from siRNA-treated cells
using the SV Total RNA Isolation System (Promega,

Madison, WI, USA) and converted to cDNA using
the Revert Aid FirstStrand cDNA Synthesis kit
(Fermantas, Vilnius, Lithuania). Five microliters of
cDNA were used in quantitative PCR in which the
qPCR results were standardized to G6PDH. Primers
(IDT, Coralville, IA, USA) and hybridization probes
(TIB Mol Biol, Berlin, Germany) shown in Table 2
were designed using the LightCycler Probe Design
Software (Roche Diagnostics). Three independent
cell-culture experiments were used to calculate the
average value of gene expression.
DNA methylation analysis
For methylation analysis on the promoter
region of the CDKN2A gene, genomic DNA was
isolated from siRNA-treated cells using the standard
method and 1 μg was digested with the methylationsensitive restriction enzyme HpaII to eliminate nonmethylated DNA sequences. Subsequently, DNA was
exposed to bisulfite modification using the EZ DNA
Methylation Gold kit (Zymo-Research, Orange, CA,
USA) according to the manufacturer’s instructions;
100 ng of modified DNA was used for methylation
analysis. The methylation assay used consisted of a
2-step approach performed as described previously
(14) and included a positive control that consisted of
in vitro methylated DNA of HeLa cells.

Table 2. Primer and probe sequences to analyze the CDKN2A gene expression.

Primers

Probes

Strand (5’ to 3’)
F
CACCGAATAGTTACGGTCGG
R
GGCGGGGTCGGCGAGTTGG
GATGGGCAGCGCCCGGATGCG-FLU
LC640-GAGCTGCTGCTCCACGGCG-P

The quenching probe is labeled with flourescein (FL), and the reporter probe with LC640 at its 5’ end.
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Statistical analyses
In order to test the effectiveness of the D-siRNA
and mDsiRNA molecules on the gene expression
or epigenetic parameters, the Mann-Whitney U
test was used to compare the results of transfection
experiments and DNA and histon methylation
analyses.
Results and discussion
We transfected HeLa cells with 50 nM 27mer
D-siRNA. This has been reported to suppress
402
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Formaldehyde was added to the cells to a final
concentration of 1.42% 48 h post-transfection
and incubated for 15 min at RT. To quench the
formaldehyde, glycine (125 mM) was added and
incubated for 5 min at RT. Cells were harvested by
scraping and collected by centrifugation at 2000
×g for 5 min at 4 °C, washed twice with PBS. For
lysis of cells, pellets were resuspended in 200 μL of
IP buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5,
5 mM EDTA, 0.5% NP-40 (V/V), 1% Triton x-100
(V/V) and protease inhibitors) and homogenized
by pipetting up and down several times. To remove
insoluble material, lysates were centrifugated at
12,000 ×g for 1 min at 4 °C. Following washing, the
nuclear pellet was sonicated in 200 μL of IP buffer,
and the lysate was cleared by centrifuging at 12,000
×g for 10 min at 4 °C. The supernatant was divided
into 2 aliquots; one was used as DNA input. The
supernatant of the 2nd aliquot was added to protein
A agarose beads that had been blocked with 2%
BSA and pre-incubated with ChIP-grade antibody
against H3K27me3 for 4 h and incubated overnight.
The beads were washed for 20 min each with high
salt, low salt, LiCl, and TE buffers, and DNA/histone
complexes were eluted twice by adding 150 μL of
elution buffer (100 mM NaHCO3 and 1% SDS) and
incubating for 15 min at 65 °C. Following Proteinase
K treatment, DNA was purified using an appropriate
purification kit, suspended in 65 μL of water and
stored at –20 °C. Then 3 μL of ChIP-associated DNA
was amplified by real-time PCR using SYBR Green
as fluorescence molecule and primers specific to
the CDKN2A promoter region, and quantitation of
CDKN2A-specific sequences in immunoprecipitated
DNA was performed as reported previously (15).

gene expression effectively (12). Forty-eight hours
later, the expression level of the CDKN2A was
determined relative to G6PDH. Results of this
experiment showed that D-siRNA is highly effective
in suppressing the CDKN2A gene. As depicted in
Figure 1a, expression level of the CDKN2A gene in
the cells transfected with D-siRNA was reduced by
average 94% when compared with cells transfected
with its mutant version (mD-siRNA), showing the
functionality of the non-validated D-siRNA. The
extent of suppression through the D-siRNA is higher
than the rates reported previously (10,12). However,
extent of knockdown of a given gene may be affected
by several factors including the characteristics of the
sequence of interest, localization of the sequence
relative to regulatory sequences, etc. We also showed

a
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Figure 1. (a) Knock-down of the CDKN2A gene by the D-siRNA;
50 nM of the D-siRNA and its mutant version was
transfected into HeLa cells, and 48 h post-transfection
the expression of the CDKN2A was analyzed relative
to G6PDH in qPCR. Shown is also untreated control.
(b) Dose-dependent gene suppression by the
D-siRNA. HeLa cells were transfected with indicated
concentrations of the D-siRNA, and the CDKN2A
expression was analyzed as described above.
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that with decreasing concentrations of the D-siRNA
the degree of silencing was also reduced (Figure 1b),
suggesting that suppression is dose-dependent.
As our target sequence compromises the promoter
and the early coding region, the observed effect may
result from suppression at the transcriptional and/
or post-transcriptional level. To find out whether
the knockdown of the CDKN2A is associated with
repressive chromatin changes we used the histone
deacetylase inhibitor trichostatin A (TSA). The cells
transfected with the D-siRNA (50 nM) were treated
with 10 ng/mL of TSA for an additional 24 h, and
the expression level of the CDKN2A was analyzed.
The test revealed that suppression of the CDKN2A
through D-siRNA was not affected by TSA treatment
(Figure 2a), indicating that chromatin changes are
not involved in the D-RNA-induced suppression.

To confirm the above finding that the D-siRNA
effect was not affected by TSA, we further investigated
DNA methylation and histone methylation in the
promoter of the CDKN2A gene. In HeLa cells no or
very low levels of CDKN2A promoter methylation
have been reported (16). Concordantly, very low levels
of basal methylation were also detected in these cells.
Upon D-siRNA treatment, no significant change in
the basal rate methylation was found, excluding DNA
methylation as a repressive epigenetic mark (Figure
2b). The trimethylation of the histone H3 lysine 27
(H3K27) is another epigenetic mark associated with
gene silencing (17). Similar to DNA methylation,
following D-siRNA treatment no significant change
was found in the amount of trimethylated H3K27
(Figure 2c). These findings suggest that the D-siRNA
directed CDKN2A suppression occurs not at

1.2
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120
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control

D-siRNA
+ TSA

mD-siRNA
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Input
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Figure 2. (a) Effect of TSA on the D-siRNA-induced suppression. Transfected cells were incubated in the presence (10 ng/mL) or
absence of TSA for additional 24 h, and the CDKN2A expression was analyzed. Note that TSA had no effect on the D-siRNAinduced suppression. (b) Role of DNA methylation in the D-siRNA effect. Following incubation, DNA methylation was
analyzed by a 2-step approach and relative methylation levels were calculated using a positive control. In the D-siRNAinduced suppression no change in the basal methylation levels was detected. (c) Involvement of H3K27me3 in the D-siRNArelated suppression. siRNA-treated cells were exposed to ChIP assay using the antibody against the H3K27me3, and CDKN2A
promoter sequences were amplified from the ChIP-associated DNA by real-time PCR. Error bars indicate standard deviations.
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transcriptional level, but likely at post-transcriptional
level.
Our finding that the D-siRNA mediated
suppression is not associated with transcriptional
events led us to speculate that following the cleavage
duplexes are introduced into the RISC assembly
preventing them from acting on transcription.
Another speculation would be that, in a sequence
like our target region in which regulatory and coding
sequences overlap, PTGS might be the dominant
mechanism of gene silencing.

that the highly efficient suppression of the CDKN2A
we observed is likely to occur at post-transcriptional
level.
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